Weight Loss Reduces Severity of Psoriasis

Published Online: Monday, June 24, 2013
Follow Pharmacy_Times:
Weight loss may help relieve psoriasis symptoms in obese patients, according to a study published online on May 29, 2013, by JAMA Dermatology. Sixty obese patients diagnosed with psoriasis were either restricted to a low calorie diet for 16 weeks or were instructed to eat healthy foods. Patients in the low calorie group improved their Psoriasis Area and Severity Index and Dermatology Life Quality Index scores.

Related Articles
The FDA today approved Novartis’ secukinumab (Cosentyx), an interleukin-17A antagonist, for the treatment of moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy.
In a head-to-head phase 3b study, Novartis’ secukinumab (Cosentyx) beat Janssen Pharmaceuticals’ ustekinumab (Stelara) in clearing the skin of patients with psoriasis.
Two doses of brodalumab generated better results in moderate-to-severe plaque psoriasis compared with ustekinumab (Stelara).
A long-term study of Celgene Corporation’s apremilast showed that the oral selective inhibitor of phosphodiesterase 4 provides relief to adult patients with active psoriatic arthritis, as well as adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$